Recent research focusing on Retatrutide at a dosage of 30mg is shedding new light on its potential effects. Early findings suggest that this higher dosage may amplify the drug's ability to manage blood sugar, potentially offering greater outcomes for individuals with diabetes. Further investigation is underway to fully evaluate the long-term impact